HIGH-RISK CANCER

This early-stage study tests a vaccine designed to train the immune system to attack cells with a specific mutation (mutant KRAS) that can lead to pancreatic cancer. The study enrolls 37 people at high risk due to family history or pancreatic abnormalities. The main goals are to …

This study tests whether taking a targeted drug (olaparib) plus hormone therapy for 6 months before prostate removal surgery can eliminate or greatly reduce cancer in men with high-risk prostate cancer and specific gene changes. About 32 men will take the drugs, then have surgery…

This phase 3 trial tests whether adding toripalimab (an immunotherapy) to capecitabine (a chemotherapy pill) as maintenance therapy works better than capecitabine alone for people with high-risk nasopharyngeal carcinoma. The study enrolls 264 adults aged 18-70 who have completed …

This study is testing whether low-dose CT scans can detect lung cancer early in over 6,600 high-risk people in Taiwan. Participants include heavy smokers who have quit, people with a family history of lung cancer, and those exposed to air pollution or other risks at work or home.…

This study is for adults 18 and older who want to learn about their personal risk of developing cancer. Researchers will collect information on diet, exercise, smoking, alcohol use, family history, and body composition. The goal is to understand risk factors and guide people towa…